April 2019 Briefing – Neurology
Here are what the editors at HealthDay consider to be the most important developments in Neurology for April 2019. This roundup includes the latest...
Diagnostic Criteria Proposed for Advanced-Age Proteinopathy
Gaps remain in understanding of limbic-predominant age-related TDP-43 encephalopathy
AAN: Cannabidiol Tied to Drop in Seizures in Dravet Syndrome
Percentage reduction in convulsive seizures higher for cannabidiol 10 and 20 mg/kg/day versus placebo
Poor Olfaction Tied to Elevated Long-Term Mortality in Seniors
Correlation evident for those who reported excellent-to-good health at baseline, not fair-to-poor health
Gender Differences Seen in Adverse Drug Reactions
Differences found in reaction symptoms and types of drugs tied to adverse reactions
Children With ADHD May Have Higher Risk for Poor Diet
However, having a poor diet does not seem to contribute to ADHD symptom development
Psychostimulant Use Pervasive in Young Adults’ Fatal Strokes
In cases of hemorrhagic stroke among young adults, psychostimulant use should be considered
Significant Number of Referred Patients Misdiagnosed With MS
At MS referral centers, almost one in five new patients have been incorrectly diagnosed with the disease
Naproxen Sodium Does Not Slow Presymptomatic Alzheimer Disease
Study shows increased frequency of adverse events but little impact on rate of change in APS
Stroke Patients Infrequently Screened, Treated for Bone Loss
5.1 percent of patients with stroke, 2.9 percent of those without prior testing had bone mineral density test
